(61) showed that miR-140-3p, miR-30c, and miR-148a can inhibit the expression of PXR and CYP3A4, respectively, by acting on the 3’UTR of PXR and reduce the elimination of anti-cancer agents in tumor cells. This evidence concerns the gene NR1I2 and neoplasm.